EUVIMEDEUVIMED entdecken
Crossref

Immune Dysregulation and Endometrial Receptivity Impairment in Women With Repeated Implantation Failure and Dyslipidemia

Yuan Zhang iD, Xiaoya Sun, YuanYuan Zhang, Yangyun Zou, Yue Zhang, Jie Wang, Li Gao, Wei Ding, Feiyang Diao iD, Jiayin Liu, Joanne Young Hee Kwak-Kim iD, Xiang Ma iD

The Journal of Clinical Endocrinology & Metabolism · 16.10.2025 · 110 (11) · 3230-3242

DOI: 10.1210/clinem/dgaf100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 20.02.2025. Verfasst von Yuan Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Reproductive Medicine and Offspring Health, Center of Reproductive Medicine, The First Affiliated Hospital of Nanjing Medical…. Hauptthemen laut MEDLINE: Dyslipidemias, Embryo Implantation, Endometrium, Infertility, Female. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: National Key R&D Program of China, Jiangsu Province Capability Improvement Project through Science, Technology and Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Dyslipidemia adversely affects reproduction outcomes; however, its relation with repeated implantation failure (RIF) remains unclear.

Objective

This study aims to analyze the impact of dyslipidemia on assisted reproductive technology (ART) outcomes, endometrial transcriptome, and microbiome of RIF women.

Design

A retrospective real-world analysis and prospective study.

Setting

University clinic. Patients 6499 infertile women, including 5618 non-RIF and 881 RIF.

Interventions

Dyslipidemia. Main Outcome Measures Implantation rate (IR), clinical pregnancy rate (CPR), and live birth rate (LBR) were compared in RIF women with or without dyslipidemia. Results of endometrial studies, including RNA sequencing (RNA-seq)-based endometrial receptivity test (ERT), 16S rRNA-based microbiome study, next-generation sequencing (NGS)-based gene comparison, and bulk RNA-seq deconvolution analysis were analyzed.

Results

The prevalence of dyslipidemia in RIF women was significantly higher. In dyslipidemia women, IR, CPR, and LBR were significantly lower, and the prevalence of nonreceptive ERT and the presence of endometrial pathogenic bacteria were higher than those of controls. After the personalized treatment, CPR 73.3% and LBR 60.0% were achieved in dyslipidemia women. NGS revealed that 176 differentially expressed genes in the endometrium of RIF women with dyslipidemia compared to those without, suggesting highly enriched in cholesterol and steroid biosynthesis and monocyte differentiation processes. An increased endometrial CD56dim natural killer cells and macrophage M1/M2 ratio with dysregulated immune factors were found by bulk RNA-seq deconvolution analysis.

Conclusion

RIF women with dyslipidemia have significantly poorer ART outcomes. In women with dyslipidemia, immune homeostasis was breached in the luteal phase endometrium, implicating a possible immune mechanism for dyslipidemia-related implantation failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DyslipidemiasEmbryo ImplantationEndometriumInfertility, FemaleHumansFemaleAdultRetrospective StudiesPregnancyProspective StudiesPregnancy RateTranscriptomeReproductive Techniques, AssistedLive Birth

Stichwörter der Autor:innen

NK cellsdyslipidemiaendometrial receptivitymacrophagerepeated implantation failure

Autor:innen und Institutionen

  • State Key Laboratory of Reproductive Medicine and Offspring Health, Center of Reproductive Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, Jiangsu 210029, Chin…
  • Reproductive Medicine and Immunology, Obstetrics and Gynecology, Clinical Sciences Department, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.
  • Department of Clinical Research, Yikon Genomics Company, Ltd., Suzhou, Jiangsu 215000, China.
  • Center of Reproductive Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, Jiangsu 210011, China.

ORCID-Profile: Yuan Zhang, Feiyang Diao, Joanne Young Hee Kwak-Kim, Xiang Ma

Förderung

  • National Key R&D Program of China
  • Jiangsu Province Capability Improvement Project through Science, Technology and Education

Zitieren

APA

Zhang, Y., Sun, X., Zhang, Y., Zou, Y., Zhang, Y., Wang, J., Gao, L., Ding, W., Diao, F., Liu, J., Kwak-Kim, J. Y. H., & Ma, X. (2025). Immune Dysregulation and Endometrial Receptivity Impairment in Women With Repeated Implantation Failure and Dyslipidemia. The Journal of Clinical Endocrinology & Metabolism, 110(11), 3230-3242. https://doi.org/10.1210/clinem/dgaf100

Vancouver

Zhang Y, Sun X, Zhang Y, Zou Y, Zhang Y, Wang J, et al. Immune Dysregulation and Endometrial Receptivity Impairment in Women With Repeated Implantation Failure and Dyslipidemia. The Journal of Clinical Endocrinology & Metabolism. 2025;110(11):3230-3242. doi:10.1210/clinem/dgaf100

BibTeX
@article{Zhang2025,
  author = {Zhang, Yuan and Sun, Xiaoya and Zhang, YuanYuan and Zou, Yangyun and Zhang, Yue and Wang, Jie and Gao, Li and Ding, Wei and Diao, Feiyang and Liu, Jiayin and Kwak-Kim, Joanne Young Hee and Ma, Xiang},
  title = {Immune Dysregulation and Endometrial Receptivity Impairment in Women With Repeated Implantation Failure and Dyslipidemia},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {11},
  pages = {3230--3242},
  doi = {10.1210/clinem/dgaf100}
}
Kostenlos starten →